GAMMA Investing’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Buy
4,739
+5
+0.1% +$128 0.01% 1548
2026
Q1
$111K Sell
4,734
-128
-3% -$2.32K 0.01% 1590
2025
Q4
$69K Buy
4,862
+2,698
+125% +$51K ﹤0.01% 1852
2025
Q3
$53.6K Sell
2,164
-853
-28% -$19K ﹤0.01% 1936
2025
Q2
$68.5K Sell
3,017
-2,795
-48% -$66.2K ﹤0.01% 1703
2025
Q1
$176K Buy
5,812
+3,428
+144% +$131K 0.01% 835
2024
Q4
$94.5K Buy
2,384
+1,721
+260% +$77.6K 0.01% 1151
2024
Q3
$42K Buy
663
+241
+57% +$17.4K ﹤0.01% 1624
2024
Q2
$28.5K Sell
422
-9
-2% -$628 ﹤0.01% 1616
2024
Q1
$34.1K Buy
431
+112
+35% +$9.16K 0.01% 1282
2023
Q4
$26.2K Buy
+319
New +$23.6K 0.01% 1316

Other funds holding ACHC

GAMMA Investing's ACHC Position: Q2 2026 in Review

GAMMA Investing increased its Acadia Healthcare (ACHC) stake by 0.11% in Q2 2026, buying an estimated $128 and bringing the position to 4,739 shares worth $140K. The position accounts for 0.01% of the portfolio, ranked #1548.

GAMMA Investing first reported a position in ACHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $176K in Q1 2025. 38 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • GAMMA Investing held 4,739 shares of Acadia Healthcare worth $140K as of Q2 2026.
  • GAMMA Investing bought 5 Acadia Healthcare shares in Q2 2026, an estimated $128.
  • Acadia Healthcare made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1548 holding.
  • GAMMA Investing first reported a position in Acadia Healthcare in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Acadia Healthcare position peaked at $176K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.